Germline polymorphisms of glutathione-S-transferase GSTM1, GSTT1 and p53 codon 72 in cervical carcinogenesis

Human Cell

Volumn 23, Issue 4, 2010, Pages 119-125

  Ueda, Masatsugu ^a   Toji, Eisaku ^a   Nunobiki, Osamu ^b   Sato, Naomi ^a   Izuma, Shinji ^a   Torii, Kiyo ^a   Okamoto, Yoshiaki ^a   Noda, Sadamu ^a  

^a Osaka Cancer Prevention and Detection Center   (Japan)

^b KOBE TOKIWA UNIVERSITY   (Japan)

Author keywords

Cervical cancer; Glutathione S transferase; P53; Polymorphism

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; PROTEIN P53;

ARTICLE; CANCER GRADING; CARCINOGENESIS; CODON; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ALPHAPAPILLOMAVIRUS; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, SQUAMOUS CELL; CODON; FEMALE; GENES, P53; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 78650244168     PISSN: 09147470     EISSN: 17490774     Source Type: Journal    
DOI: 10.1111/j.1749-0774.2010.00089.x     Document Type: Article

References (32)

1. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000; 92: 690-8.
2. Tew KD. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 1994; 54: 4313-20.
3. Singhal SS, Zimniak P, Awasthi S et al. Several closely related glutathione S-transferase isoenzymes catalysing conjugation of 4-hydroxynonenal are differentially expressed in human tissues. Arch Biochem Biophys 1994; 311: 242-50.
4. Baez S, Segura-Aguilar J, Widersten M et al. Glutathione transferases catalyse the detoxification of oxidised metabolites (Ο-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem J 1997; 324: 25-8.
5. Goodman MT, McDuffie K, Hernandez B et al. CYP1A1, GSTM1, and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in a multiethnic population. Gynecol Oncol 2001; 81: 263-9.
6. Ara S, Lee PSY, Hansen MF et al. Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res 1990; 18: 4961.
7. Fan R, Wu MT, Miller D et al. The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000; 9: 1037-42.
8. Liu G, Miller DP, Zhou W et al. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma. Cancer Res 2001; 61: 8718-22.
9. Miller DP, Liu G, De Vivo I et al. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Cancer Res 2001; 62: 2819-23.
10. Lee JM, Lee YC, Yang SY et al. Genetic polymorphisms of p53 and GSTP1, but not NAT2, are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 2000; 89: 458-64.
11. Zehbe I, Voglino G, Wilander E et al. Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet 1999; 354: 218-19.
12. Storey A, Thomas M, Kalita A et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature (Lond) 1998; 393: 229-34.
13. Warwick A, Sarhanis P, Redman C et al. Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smoking. Carcinogenesis 1994; 15: 2841-5.
14. Chen C, Madeleine MM, Weiss NS et al. Glutathione S-transferase M1 genotypes and the risk of squamous carcinoma of the cervix: a population-based case-control study. Am J Epidemiol 1999; 150: 568-72.
15. Rosenthal AN, Ryan A, Al-Jehani RM et al. p53 codon 72 polymorphism and the risk of cervical cancer in UK. Lancet 1998; 352: 871-2.
16. Lanham S, Campbell I, Watt P et al. p53 polymorphism and risk of cervical cancer. Lancet 1998; 352: 1631.
17. Hayes VM, Hofstra RMW, Buys CHCM et al. Homozygous arginine-72 in wild type p53 and risk of cervical cancer. Lancet 1998; 352: 1756.
18. Chen CL, Liu Q, Relling MV. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 1996; 6: 187-91.
19. Ueda M, Gemmill RM, West J et al. Mutations of the β- and γ-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer 2001; 85: 64-8.
20. Nagano H, Yoshikawa H, Kawana T et al. Association of multiple human papillomavirus types with vulvar neoplasias. J Obstet Gynecol Res 1996; 22: 1-8.
21. Yoshikawa H, Kawana T, Kitagawa K et al. Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 1991; 82: 524-31.
22. Meyer DJ, Christodoulides LG, Hong-Tan K et al. Isolation, properties and tissue distribution of rat glutathione transferase E. FEBS Lett 1984; 173: 327-30.
23. Chen H, Sandler DP, Taylor JA et al. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 1996; 347: 295-7.
24. Elexpuru-Camiruaga J, Buxton N, Kandula V et al. Susceptibility to astrocytoma and meningioma. Influence of allelism at glutathione S-transferase GSTT1 and GSTM1 and cytochrome P450 CYP2D6 loci. Cancer Res 1995; 55: 4237-9.
25. Joseph T, Chacko P, Wesley R et al. Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection. Gynecol Oncol 2006; 101: 411-17.
26. Ueda M, Hung YC, Terai Y et al. Glutathione S-transferase GSTM1, GSTT1 and p53 codon 72 polymorphisms in human tumor cells. Hum Cell 2003; 16: 241-51.
27. Marin MC, Jost CA, Brooks LA et al. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet 2000; 25: 47-54.
28. Brooks LA, Tidy JA, Gusterson B et al. Preferential retention of codon 72 arginine p53 in squamous cell carcinomas of the vulva occurs in cancers positive and negative for human papillomavirus. Cancer Res 2000; 60: 6875-7.
29. Koushik A, Platt RW, Franco EL. p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev 2004; 13: 11-22.
30. Minaguchi T, Kanamori Y, Matsushima M et al. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res 1998; 58: 4585-6.
31. Yamashita T, Yaginuma Y, Saitoh Y et al. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix. Carcinogenesis 1999; 20: 1733-6.
32. Klug SJ, Ressing M, Koenig J et al. TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol 2009; 10: 772-84.